Passa al contenuto
Merck
  • Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling.

Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling.

Stem cells (Dayton, Ohio) (2014-12-30)
Sang Hun Lee, Kyeung Bin Lee, Jun Hee Lee, Songhwa Kang, Hwi Gon Kim, Takayuki Asahara, Sang Mo Kwon
ABSTRACT

The Lnk adaptor protein is a strong negative regulator that affects self-renewal of hematopoietic stem cells and vascular repair in injured tissues. However, the signaling mechanisms through which these proteins influence the vascular regeneration function of endothelial progenitor cells (EPCs) remain unknown. In this study, we investigated the effect of Lnk-targeted small interfering RNA (si-lnk) on the clonogenic proliferative potential and vascular regenerative function of EPCs and the activation of the JAK/STAT3 signaling pathway. Treatment with stem cell factor (SCF) increased the clonogenic proliferation of si-lnk EPCs. Importantly, activation of the JAK2/STAT3 pathway was enhanced in SCF-sensitized si-lnk EPCs. In a hind limb model of ischemia, transplantation of si-lnk EPCs increased the blood flow ratio, capillary density, proliferation, and survival of transplanted cells, and the secretion of pivotal angiogenic cytokines at ischemic sites. These results provide strong evidence that si-lnk regulates the clonogenic proliferative potential of EPCs through the activation of the JAK2/STAT3 signaling pathway, thereby accelerating angiogenesis and promoting repair in injured hind limb ischemia. Stem Cells 2014;33:1490-1500.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Acido L-ascorbico, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
Acido L-ascorbico, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Acido L-ascorbico, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Acido L-ascorbico, reagent grade, crystalline
USP
Acido ascorbico, United States Pharmacopeia (USP) Reference Standard
Supelco
Acido L-ascorbico, analytical standard
Sigma-Aldrich
Acido L-ascorbico, reagent grade
Sigma-Aldrich
Acido L-ascorbico, meets USP testing specifications
Sigma-Aldrich
Acido L-ascorbico, FCC, FG
Sigma-Aldrich
Acido L-ascorbico, 99%
Sigma-Aldrich
Acido L-ascorbico, BioUltra, ≥99.5% (RT)
Supelco
Acido L-ascorbico, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Vinylene carbonate, contains ≤2% BHT as stabilizer, 97%
Sigma-Aldrich
Acido L-ascorbico, ACS reagent, ≥99%
Sigma-Aldrich
Acido L-ascorbico, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Acido L-ascorbico, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Acido L-ascorbico, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
Acido L-ascorbico, tested according to Ph. Eur.
Supelco
Acido L-ascorbico, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Stat3
Sigma-Aldrich
MISSION® esiRNA, targeting human STAT3
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Sh2b3
Sigma-Aldrich
MISSION® esiRNA, targeting human SH2B3